Johnny Huard Recognized for Orthobiologics Research

The American Academy of Orthopaedic Surgeons (AAOS) has bestowed the Arnold I. Caplan Award for Distinguished Research in Orthobiologics (Caplan Award) upon Johnny Huard, Ph.D. The award honors the legacy of Arnold Caplan, Ph.D., a pioneer in orthobiologics and medicinal signaling cells (MSCs), by recognizing exceptional, sustained contributions that advance biologics-based solutions for musculoskeletal injuries and disease.

The Caplan Award recognizes Dr. Huard for his nearly three decades of research on adult stem cells and their role in tissue regeneration and repair. Among his most significant discoveries is the identification and isolation of MSCs from adult skeletal muscle, also known as muscle-derived stem cells (MDSCs). These cells exhibit key stem cell characteristics and have been widely used in tissue engineering and regenerative medicine applications to treat tissues affected by injury, disease, and aging.

“Dr. Caplan challenged the field to rethink how mesenchymal stem cells function and how they contribute to tissue homeostasis and repair,” Dr. Huard said. “Our work helped provide the biological context and experimental evidence to support his vision that MSCs’ primary role is signaling, not replacement. It is an honor to receive an award that bears his name and to contribute to a body of science that continues to shape regenerative medicine and orthopedic care.”

Dr. Huard is the chief scientific officer and director of the Linda & Mitch Hart Center for Regenerative and Personalized Medicine at Steadman Philippon Research Institute (SPRI) in Vail, Colo. His work has helped define MSCs’ origin and mechanism of action. Dr. Huard’s research has shown these cells reside within blood vessels, directly supporting Dr. Caplan’s long-held assertion that all MSCs originate as perivascular cells. Further, Dr. Huard advanced the field by demonstrating that MSCs exert their therapeutic effect primarily through paracrine signaling, releasing bioactive factors that drive angiogenesis, regeneration, and repair. Through this characterization and investigation of bioactive factors, Dr. Huard and his team have broadened their research portfolio to include the therapeutic benefit of extracellular vesicles in addition to MSCs.

“Dr. Huard has been a leader and innovator in biologics research for over thirty years,” SPRI Chairman Marc J. Philippon, M.D., stated. “We are grateful to AAOS’s recognition of Dr. Huard’s commitment to advancing the field of regenerative medicine research and his dedication to improving patient care.”

Created through the generosity of the Caplan family with funding overseen by the Orthopaedic Research and Education Foundation (OREF), the Caplan Award recognizes excellence in orthobiologics research. The award includes a desktop recognition piece and a $10,000 monetary prize.

“Dr. Caplan laid the groundwork by transforming our understanding of mesenchymal stem cells and their role in tissue repair,” commented Jason L. Dragoo, M.D., chair of the AAOS Committee on Devices, Biologics and Technology. “Dr. Huard’s research provided critical biological and clinical context for that vision, helping establish MSCs as pericytes and advancing the concept of medicinal signaling cells. His work exemplifies the innovative spirit that continues to drive meaningful progress in orthobiologics and improve outcomes for patients.”

With more than 39,000 members, AAOS is the world’s largest medical association of musculoskeletal specialists. The organization advances musculoskeletal health by providing comprehensive education to help orthopedic surgeons and allied health professionals best treat patients in their daily practices. AAOS is the source for information on bone and joint conditions, treatments, and related musculoskeletal healthcare issues; and it leads the healthcare discussion on advancing quality.

An independent 501(c)3 nonprofit, OREF strives to improve clinical care and patient outcomes by advancing research, developing new investigators, and uniting the orthopedic community in promoting musculoskeletal health. The Foundation raises funds to support research on diseases and injuries of bones, nerves, muscles, and tendons, and to enhance clinical care leading to improved health, increased activity, and a better quality of life for patients.